Technical Analysis for IPA - ImmunoPrecise Antibodies Ltd.

Grade Last Price % Change Price Change
F 14.65 -2.27% -0.34
IPA closed down 2.27 percent on Friday, January 15, 2021, on 60 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical IPA trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
Hot IPO Pullback Bullish Swing Setup -2.27%
Doji - Bullish? Reversal -2.27%
Hot IPO Pullback Bullish Swing Setup -2.07%
NR7 Range Contraction -2.07%
Bearish Engulfing Bearish -5.81%
Doji - Bearish? Reversal -11.75%
New 52 Week High Strength -11.75%
New 52 Week High Strength -9.12%
New 52 Week Closing High Bullish -12.43%
Older End-of-Day Signals for IPA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% 2 days ago
Down 2 % 2 days ago
Down 1% 2 days ago
Fell Below Previous Day's Low 2 days ago
Up 1% 3 days ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ImmunoPrecise Antibodies Ltd. Description

ImmunoPrecise Antibodies Ltd. engages in the antibody production and related services in the United States, Canada, Europe, and internationally. Its services include B cell sorting, screening and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multispecies antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing, purification in gram scale levels, and characterization and validation; antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with screening and clone-picking; cryopreservation; affinity measurements, functional assays, and epitope mapping and binning; and modeling, design, and manufacturing of custom antigen. The company has a collaboration with University of Victoria to develop a saliva-based antibody-based test for the detection and screening of COVID-19; Zymeworks Inc. for the development of multiple antibody candidates to fight COVID-19; and National Research Council of Canada's Human Health Therapeutics Research Centre to develop neutralizing PolyTope antibodies against SARS-CoV-2, as well as a research partnership with Mila. ImmunoPrecise Antibodies Ltd. was founded in 1989 and is headquartered in Fargo, North Dakota.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Medicine Immunology Antibodies Monoclonal Antibody Antibody Cloning

Is IPA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.48
52 Week Low 13.17
Average Volume 43,135
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 15.56
Average True Range 0.00
ADX 0.0
+DI 0.00
-DI 0.00
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.64
Resistance 3 (R3) 15.64 15.31 15.47
Resistance 2 (R2) 15.31 15.06 15.31 15.42
Resistance 1 (R1) 14.98 14.90 14.82 14.98 15.36
Pivot Point 14.65 14.65 14.57 14.65 14.65
Support 1 (S1) 14.32 14.40 14.16 14.32 13.94
Support 2 (S2) 13.99 14.25 13.99 13.88
Support 3 (S3) 13.67 13.99 13.83
Support 4 (S4) 13.66